Business & Financial News, Breaking US & International News | Reuters
Edition:
United States

Investment Banking & Brokerage Services

Page 2

Share PLC announces contract with Barclays

Wednesday, 4 Mar 2015 02:00am EST

Share PLC:Which operates The Share Centre, says The Share Centre has signed a three year contract with Barclays Stockbrokers, a division of Barclays Bank plc, to provide certificated dealing services to customers introduced to it by Barclays.

Investec Asset Management extends relationship with State Street Corp

Thursday, 5 Feb 2015 09:30am EST

State Street Corp:Says that it has extended its relationship with Investec Asset Management for another seven years to provide full middle office and fund accounting services across the UK, South Africa, Luxembourg and the United States.

Currency Exchange International announces new agreements with nine financial institutions

Thursday, 16 Oct 2014 09:23am EDT

Currency Exchange International Corp:Signs new agreements with nine financial institutions located in United States for services including exchange of foreign banknotes, foreign cheque clearing, and foreign bank draft issuances.Agreements provide financial institutions access to CXI's proprietary software, CEIFX, to fulfill processing of foreign banknotes, foreign cheque clearing, and foreign bank draft issuances.Depending on internal policies of each bank, banks will provide such services downstream to account holders and non-account holders through CEIFX's ordering system.The nine financial institutions represent more than 1,100 distinct locations across 14 states.Such services have been implemented with most of these institutions already, with remaining transacting locations set to be online within next two months.

Oragenics Inc selects Merriman Holdings Inc's Merriman Capital as capital markets advisor

Thursday, 18 Sep 2014 09:00am EDT

Merriman Holdings Inc:Merriman Capital, Inc. (Merriman), wholly owned subsidiary of Merriman Holdings, Inc. (MERR), announces that it has been selected as Capital Markets Advisor to Oragenics, Inc.Oragenics is focused on becoming world leader in novel antibiotics against infectious disease and therapeutic probiotics for oral health in humans and pets.Company also develops, markets and sells proprietary OTC probiotics specifically designed to enhance oral health for humans and pets, under the brand names Evora and ProBiora3 in US and internationally.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider : Renaissance Capital
$115.00
Provider : Renaissance Capital
$81.00
Provider : Renaissance Capital
$58.00
Provider : Renaissance Capital
$81.00
Provider : Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.